This inventor holds 3 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Genentech, Inc., Hoffmann-La Roche Inc.. Active years: 2020-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 3,302 
3 out of 5,027 
Years Active: 2020-2025
Title: Tanja Badovinac-Crnjevic: Innovator in Cancer Treatment
Introduction
Tanja Badovinac-Crnjevic is a prominent inventor based in Basel, Switzerland. She has made significant contributions to the field of cancer treatment through her innovative patents. With a total of 3 patents, her work focuses on improving therapeutic options for patients.
Latest Patents
One of her latest patents is the "Pertuzumab plus trastuzumab fixed dose combination." This invention concerns a fixed dose combination (FDC) of pertuzumab, trastuzumab, and, optionally, recombinant human hyaluronidase (rHuPH20), which is administered subcutaneously to patients. The patent includes final efficacy and safety data for the FeDeriCa clinical trial, as well as the United States Prescribing Information (USPI) and primary analysis of the PHranceSCa clinical trial. Another significant patent is for "Subcutaneous HER2 antibody formulations." This patent provides fixed dose HER2 antibody formulations for subcutaneous administration, including fixed dose subcutaneous formulations of pertuzumab and co-formulations of pertuzumab and trastuzumab for cancer treatment.
Career Highlights
Tanja has worked with leading companies in the pharmaceutical industry, including Genentech, Inc. and Hoffmann-La Roche Inc. Her experience in these organizations has allowed her to develop groundbreaking treatments that enhance patient care.
Collaborations
Throughout her career, Tanja has collaborated with talented individuals such as Whitney Kirschbrown and Sarah Heeson. These partnerships have contributed to her success and the advancement of her innovative ideas.
Conclusion
Tanja Badovinac-Crnjevic is a remarkable inventor whose work in cancer treatment has the potential to change lives. Her patents reflect her dedication to improving therapeutic options for patients, and her collaborations further enhance her contributions to the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile